T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Element Solutions
ESI
$9.51B
| $95.9M | 0.01% |
8,839,290
+2,345,906
| +36% | +$23.6M |
|
652
Brink's
BCO
$4.72B
| $95.5M | 0.01% |
2,097,992
-424,203
| -17% | -$19.3M |
|
653
National Fuel Gas
NFG
$7.75B
| $95.4M | 0.01% |
2,275,863
+1,722,222
| +311% | +$70.3M |
|
654
Scholastic
SCHL
$784M
| $94.6M | 0.01% |
3,161,039
-5,776
| -0.2% | -$166K |
|
655
McKesson
MCK
$99.9B
| $94.4M | 0.01% |
615,334
-216,088
| -26% | -$31.2M |
|
656
Flowserve
FLS
$10.3B
| $94.3M | 0.01% |
3,305,803
-93,664
| -3% | -$2.5M |
|
657
Primerica
PRI
$9.62B
| $94.2M | 0.01% |
808,288
-511
| -0.1% | -$54.3K |
|
658
Banco Bradesco
BBD
$34.3B
| $94.1M | 0.01% |
29,887,050
-2,248,002
| -7% | -$6.84M |
|
659
Constellium
CSTM
$3.95B
| $93.8M | 0.01% |
12,210,745
+815,172
| +7% | +$5.92M |
|
|
ATRI
660
DELISTED
Atrion Corp
ATRI
| $92.3M | 0.01% |
144,962
-822
| -0.6% | -$538K |
|
|
DCPH
661
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $91.9M | 0.01% |
1,538,700
+62,879
| +4% | +$3.36M |
|
662
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $91.6M | 0.01% |
4,490,573
-149,899
| -3% | -$3.04M |
|
663
Safety Insurance
SAFT
$1.52B
| $90.4M | 0.01% |
1,186,006
+8,200
| +0.7% | +$642K |
|
664
Chemed
CHE
$7.02B
| $90.1M | 0.01% |
199,736
-14,858
| -7% | -$6.63M |
|
|
EBSB
665
DELISTED
Meridian Bancorp, Inc.
EBSB
| $89.9M | 0.01% |
7,752,288
-5,870
| -0.1% | -$65.2K |
|
666
Axsome Therapeutics
AXSM
$11.2B
| $89.3M | 0.01% |
1,084,871
+339,511
| +46% | +$26.1M |
|
667
CACI
CACI
$14.8B
| $88.7M | 0.01% |
408,858
+67,338
| +20% | +$16.1M |
|
668
Federal Realty Investment Trust
FRT
$10.3B
| $88.4M | 0.01% |
1,037,875
-173,011
| -14% | -$14M |
|
|
AIMT
669
DELISTED
Aimmune Therapeutics
AIMT
| $88.1M | 0.01% |
5,274,902
+82,229
| +2% | +$1.4M |
|
670
SPX Corp
SPXC
$10.6B
| $88.1M | 0.01% |
2,140,852
+131,860
| +7% | +$4.97M |
|
|
HMSY
671
DELISTED
HMS Holdings Corp.
HMSY
| $88.1M | 0.01% |
2,719,177
-35,680
| -1% | -$1.03M |
|
|
BLUE
672
DELISTED
bluebird bio
BLUE
| $87.9M | 0.01% |
111,217
+10,280
| +10% | +$7.75M |
|
673
Casella Waste Systems
CWST
$5.79B
| $87.2M | 0.01% |
1,672,170
-17,796
| -1% | -$849K |
|
674
Exponent
EXPO
$3.24B
| $87.1M | 0.01% |
1,076,784
-10,972
| -1% | -$790K |
|
675
Prudential Financial
PRU
$43B
| $86.9M | 0.01% |
1,426,437
+607,369
| +74% | +$35.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.